Semi-Annual Consolidated Statement Of Cash Flows

Medrx Co.,Ltd. - Filing #7571296

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,071,985,000 JPY
-928,543,000 JPY
Interest and dividends received
17,000 JPY
13,000 JPY
Interest paid
JPY
-1,473,000 JPY
Income taxes paid
-2,502,000 JPY
-1,501,000 JPY
Net cash provided by (used in) operating activities
-1,073,292,000 JPY
-923,688,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,958,000 JPY
-2,542,000 JPY
Net cash provided by (used in) investing activities
-1,958,000 JPY
-2,542,000 JPY
Cash flows from financing activities
Repayments of short-term borrowings
JPY
-50,000,000 JPY
Proceeds from issuance of bonds
JPY
550,000,000 JPY
Redemption of bonds
JPY
-550,000,000 JPY
Purchase of treasury shares
0 JPY
JPY
Net cash provided by (used in) financing activities
356,315,000 JPY
815,915,000 JPY
Effect of exchange rate change on cash and cash equivalents
9,316,000 JPY
1,599,000 JPY
Net increase (decrease) in cash and cash equivalents
-709,619,000 JPY
-108,715,000 JPY
Cash and cash equivalents
994,025,000 JPY
1,703,644,000 JPY
1,812,360,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.